The cardiomyopathy developed by patients with chronic Chagas disease (CCD), one of the most severe consequences of T. cruzi infection, is mainly associated with an imbalance between an excessive inflammatory reaction and a defective immunomodulatory profile cause by host-parasite interaction. Despite the growing importance of the regulatory function of B-cells in many malignancies, few studies have addressed their immunosuppressive role in chronic Chagas disease. In this work, we tackled this issue by studying the proportion of different B cell subpopulations and their capacity to secrete IL-10 in individuals with distinct clinical forms of CCD. Seven-colour flow cytometry was performed to examine the peripheral blood B cell compartment in chronic Chagas disease (CCD) patients with and without cardiac manifestations (n=10 for each group) and non-infected donors (n=9). Peripheral blood mononuclear cells (PBMC)
INTRODUCTION
Chagas disease, a serious health problem caused by the infection with the protozoan parasite Trypanosoma cruzi, comprises an acute and a chronic phase. During the latter, the disease may remain without any detectable symptoms for several decades, or progress toward cardiac or digestive forms, or even a combination of these alterations (1) .
The absence of any symptoms as well as the inflammatory mechanisms leading to tissue damage is attributed mainly to the immune response developed by the host against the parasite, and to the different means by which the parasite avoids it and persists. Several reports demonstrate a predominance of a humoral and cellular pro-inflammatory environment in cardiac patients, while an anti-inflammatory response seems to prevail in infected subjects without cardiac manifestation (2) (3) (4) .
Regulatory B (Breg) cells are a specific B cell subset allocated to restrain the excessive inflammatory response accomplished in different immune-related pathologies, such as autoimmune and allergic diseases, malignancies, infections and solid organ transplantation (5, 6) . Through IL-10 production, Breg cells have the capacity to suppress the function and proliferation of Th1, Th17 and follicular helper T (TFH) cells, increase polarization of T cells towards the regulatory T (Tregs) cell profile, repress the innate response by acting on antigen-presenting cells (dendritic cells, macrophages) and natural killer (NK and NKT) cells, decrease the production of IgG while inducing class switch towards IgG4, among others (7). In addition, Breg cells have also been shown to contribute to immune homeostasis by IL-10-independent mechanisms (8) . However, and due to the absence of subset-specific membrane markers or transcription factors, IL-10 secretion is still the hallmark feature used to distinguish Breg from the rest of the B cells (9, 10) . In humans, different B cell lineages that secrete this cytokine and have regulatory functions have been described, such as CD19 + CD24 high CD38 high (11) , CD19 + CD24 high CD27 + (12) , CD19 + CD5 + CD1d + (13, 14) , CD19 + Tim-1 + (15, 16) and CD19 + CD25 + CD71 + CD73cells (7), depending on the stimulation conditions and the markers used to identify them. Nowadays, the majority of the studies in human samples pinpoint the CD19 + CD24 high CD38 high immature transitional B cell population as the most representative phenotypic signature of Breg cells (17) .
In the context of Chagas disease, B cells and their role as antibody secreting cells were amongst the first and most widely studied components of immunity against T. cruzi, but little is known about the irrelevance as antigen presenting cells, cytokine producers and immune modulators (3, 18 
MATERIALS AND METHODS

Subjects included and blood sample collection
EDTA-anti coagulated blood samples were collected from patients with chronic Chagas disease (CCD) and from non-infected donors after written consent was given, in accordance with the guidelines of the protocol approved by the Medical Ethics Committee of the Instituto Nacional de Parasitología "Dr. M. Fatala Chaben" and the Hospital General de Agudos "Dr. Ignacio Pirovano". The study population included 30 subjects: 20 patients with CCD (10 with and 10 without cardiac manifestations) and 9 donors with non-reactive serological tests for Chagas disease (control group). T. cruzi chronic infection was determined, according to national and international guidelines, by at least two reactive tests (indirect immunofluorescence, enzyme-linked immunosorbent assay -ELISA-, indirect hemagglutination). All the three groups were age-and gender-matched ( Table 1) . (20) .
An aliquot of whole blood (4 ml) from each participant was separated and centrifuged for sample was used to isolate PBMC. The titre of total anti-T.cruzi IgG antibodies in the plasma of patients was determined as previously described (21) . 
RESULTS
Frequency of total and transitional B lymphocytes is altered in peripheral blood
from patients with the cardiac form of chronic Chagas disease.
In humans, four different subsets of peripheral blood B cells can be identified according to the expression levels of surface markers CD24 and CD38: CD19 + CD24 high CD38 high (immature transitional B cells), CD19 + CD24 int CD38 int (primarily mature naïve B cells), CD19 + CD24 high CD38 low (primarily memory B cells) and CD19 + CD24 low CD38 high (plasmablasts) (24, 25) . Since the combined expression of these markers has not been addressed in the context of chronic T. cruzi infection, we decided to evaluate the frequency of the subsets mentioned above within total CD19 + B cells in PBMC from CCD patients without cardiac involvement (G0, n=10), CCD patients with cardiac involvement (G1, n=10) and non-infected donors (NI, n=9). First, we analyzed the frequency of total B lymphocytes and mean fluorescence intensity (MFI) for CD19 in CD19 + cell population.
The gating strategy used to identify total B cells (CD3 -CD19 + cells) is illustrated in Sup.
Fig.1.
Results revealed higher percentage of CD19 + B cells in patients with cardiac involvement compared to non-infected donors (Fig. 1A) . No statistically significant differences were shown between G0 and NI or between CCD groups. Furthermore, similar MFI levels were found across the cohort, independently of clinical status of the subjects (Fig. 1B) .
Next, using the gating strategy represented in Fig. 1C , we quantified the frequencies of different B cell subsets according to CD24 and CD38 expression in CCD patients and NI group. Results showed that the frequency of transitional B cells (CD24 high CD38 high ) within total B cells were higher in patients with cardiac involvement from than those from noninfected donors. In addition, no significant differences were observed in the frequencies of the other B cell subpopulations among the groups (Fig. 1D ). Then, we determined the frequency of B cell subsets according to the expression of markers CD24 and CD27 or CD27 and CD38. The gating strategy to evaluate each subset of cells in a representative donor sample is illustrated in Fig. 2A and Fig. 2B . No differences among the groups were detected in any of the subpopulations evaluated ( Fig.   2C and Fig. 2D ). Since CD24 high CD38 high transitional B cell population has been associated with IL-10mediated, regulatory B cell functions in autoimmune and infectious human diseases (11, 26, 27) , we next studied IL-10 producing B cells (B10 cells) in peripheral blood from patients with the different clinical forms of CCD. Thus, we performed an intracellular flow cytometry on PBMC, after in vitro incubation with PMA and ionomicyn in the presence of the protein transport inhibitor Brefeldin A for 5 h. We assessed the frequency of total B10 cells and B10 cell subsets according to CD24, CD38 and CD27 expression (11, 27) (Fig.   3 ). The gating strategy is shown in Sup. Fig.1 and Fig 3A. Results showed that patients with the cardiac form (G1) have a tendency, although non-statistically significant to a decreased frequency of B10 cells compared to non-infected donors (Fig 3B) . Furthermore, no differences in MFI of IL-10 in IL-10 + B cells were observed among the groups (Fig. 3C) .
The analysis of phenotypic distribution of B10 cells revealed that, for G0 and non-infected donors, most of B10 cells were contained within the naive (CD24 int CD38 int ) and memory (CD24 high CD38 low ) compartments, while a minor proportion was enclosed within the transitional subset (CD24 high CD38 high ). In contrast, in patients with cardiac involvement (G1 group) B10 cells were distributed equally between the naïve and memory subsets, with a minor proportion belonging to the transitional compartment (Fig. 3D) . In addition, the frequencies of B10 cells with transitional and naïve phenotype were higher in patients with cardiac involvement compared to those from non-infected donors (Fig. 3D) . However, only the frequency of naïve B10 cells was statistically different among the groups (Fig 3E) .
Figure 3: Frequency and phenotypic distribution of B10 cells according to CD24 and CD38 expression in peripheral blood from CCD patients and non-infected donors. (A)
Representative dot plots showing the gating strategy used to determine IL-10 + B cells (B10 cells) in PMA + Iono stimulated PBMC. Fluorescence minus one controls were used to define negative populations for each sample. (B) Frequency of B10 cells in total B cells and mean fluorescence intensity for IL-10 + in B10 cells in CCD patients (G0, G1) and non-infected donors (NI). (C) Representative dot plots showing the gating strategy used to determine B10 cell subsets (transitional, naïve and memory) according to CD24 and CD38 expression in each group. IL-10 expressing Bcells (B10 cells) were gated according to subject-and condition-matched FMO control tubes, and were further sub-gated using CD24 and CD38 to identify the phenotypical distribution of these populations. (D) Frequency distribution of B10 cells according to CD24 and CD38 expression in CCD patients (G0, G1) and non-infected donors (NI). Each dot represents data from one. Statistically significant differences among subsets of cells and groups are indicated (*p<0.05).
It is well known that CD27 expression identifies human memory B cells (28) . In order to better characterize the phenotypic distribution of B10 cells in CCD patients, we assessed the frequency of B10 cells according to CD27 expression alone and in combination with CD24 and CD38. According to CD27 expression, B10 cells were mainly found in the CD27 + (memory) population in the non-infected group, as was previously reported in samples from healthy blood donors (27) and the same pattern was observed in CCD patients (Fig. 4B) . In addition, no differences were shown in the frequency of memory (CD27 + ) and naïve (CD27 -) B10 cells subsets among the groups (Fig. 4B) .
Analysis of B10 cells subsets according to their CD24-CD27 expression showed an enrichment in CD24 -CD27cells in patients with the cardiac clinical form compared to patients with no cardiac involvement (G0 group) and non-infected donors (Fig. 4E) .
Frequencies of B10 cell subsets according to CD24-CD38 expression did not shown statistically significant differences among the groups (Fig. 4F ). and CD24 high CD27 + compartments exhibit higher frequencies of IL-10 producing cells than their respective counterparts (11, 12, 27) . Taking this into account, we aimed to evaluate the frequency of IL-10 + cells within CD24 high CD38 high and CD24 high CD27 + enriched subpopulations ( Fig. 5A and Fig. 5B respectively) . With this approach, we did not find differences between the groups (Fig 5C and 5D respectively).
Figure 5: IL-10producing cells within CD24 high CD38 high transitional and CD24 high CD27 + memory B cell populations in CCD patients and non-infected donors. (A, B) Representative dot plots showing the gating strategy used to determine frequency of IL-10 + B cells inCD24 high CD38 high andCD24 high CD27 + B cells. (C, D)
Frequencies of IL-10 + cells within transitional (CD24 high CD38 high ) and memory (CD24 high CD27 + ) compartments in CCD patients (G0, G1) and non-infected donors (NI). Each dot represents data from one subject and boxes and whiskers show median value and interquartile range.
Figure 6: IL-10 production by total lymphocytes, B cells and CD4 + /CD4 -T cells in CCD patients and non-infected donors. (A-B)
Gating strategy and frequency of IL-10 + cells determined in total lymphocytes in CCD patients (G0, G1) and non-infected donors (NI). (C) Frequency of IL-10 + cells within B (CD3 -CD19 + ) cells and T (CD3 + ) cells in PBMC from CCD patients (G0, G1) and non-infected donors (NI). Gating strategy employed is illustrated in Sup. Fig.1. (D-G) Frequency of IL-10 + cells within CD4 + and CD4 -T cell populations in CCD patients (G0, G1) and non-infected donors (NI). Each dot represents data from one subject. Statistically significant differences among groups are indicated (*p<0.05).
DISCUSSION
In this study, we characterized for the first time the B cell compartment in patients with chronic Chagas disease with and without cardiac involvement, in terms of their grouping in immature transitional (CD19 + CD24 high CD38 high ), primarily mature (CD19 + CD24 int CD38 int ), primarily memory (CD19 + CD24 high CD38 -) B cells, and plasmablasts (CD19 + CD24 -CD38 high ) (24, 25) .
We found that immature transitional peripheral blood B cells had higher frequencies in patients with cardiac involvement compared to non-infected subjects, and that this expansion could be conjoined with an increase in the percentage of total CD19 + B cells. In interferences in mature B cell development but also to an autoimmune response through polyclonal activation (35) (36) (37) (38) . Besides, another important checkpoint necessary for the development of human B cell precursors is the IL-7/IL-7R axis (39) which was found to be altered in chronic Chagas disease patients with severe cardiomyopathy (40) .
Production of IL-10 is the ultimate feature of several described B regulatory phenotypes (41) , and is the broadest phenotypic marker of human Bregs described so far (42) . Several subsets of IL-10 producing B cells have been described in humans, their definition depending on the disease under study, the immunological context and the stimulation conditions. These include CD1d + CD5 + (43, 44) , Tim-1 + (15, 16) , immature transitional CD24 hi CD38 hi (11, 41) and memory CD24 high CD27 + B cells (12) .
Focusing on chronic infections, a potent immunosuppressive role has been reported for B10 cells, acting mainly upon antigen-specific CD8 + T cells (45) . In HIV-infected children and adolescents, an increased frequency of circulating Breg cells induced by influenza immunization has been linked to a poor response to vaccination (46) . In leishmaniasis, IL-10 secreted by CD5 + CD1d + B cells polarized the Th cell response toward the Th2 phenotype, necessary for susceptibility to infection with the parasite in BALB/c mice (47) .
Even more, incubation of human B cells with Leishmania infantum amastigotes induced IL-10 production by CD24 + CD27 -B cells that modulated partially INF-γ and TNF-α secretion by T cells (48) . Although B10 cells are involved in the maintenance of homeostasis in the immune system (5, 49) , these findings highlight the importance of the immunosuppressive mechanisms triggered by microorganisms which could favor their persistence and contribute to poor vaccine response (50, 51) . Nonetheless, and given the implications of uncontrolled inflammation in the context of Chagas disease, B10 cells are likely to contribute to the delicate balance between parasite clearance and inflammatory pathogenesis.
As mentioned above, the only work attempting to analyze the role of B10 cells in chronic Chagas disease has been carried out by Fares et al (2013) (19) . Therein, T. cruzi infected patients, independently of the clinical form of the disease, presented a slightly higher frequency of IL-10-producing CD19 + CD1d + CD5 + cells compared to non-infected subjects.
Here, we found that the frequency of B10 cells was similar among the groups, but the phenotypic distribution based on CD24 and CD38 surface markers was altered in patients with cardiac involvement compared to patients without cardiac involvement and noninfected subjects. While no differences were observed in the frequency and phenotypic distribution of B10 cells between non-infected and patients without cardiac involvement, those with cardiac manifestations had significantly larger naïve and immature transitional subpopulations within B10 cells. This augmentation seems to be associated with a decrease tendency in the frequency of CD24 high CD38 low B10 cells. Interestingly, although, the other phenotype associated with Breg cells CD24 high CD27 + IL-10 producing cells, seemed not to be altered, the percentage of CD24 -CD27cells was also significantly increased in patients with cardiac manifestations. The functional features of this subpopulation remain elusive and the relevance of this augmentation will be a matter of further investigation in our laboratory.
Because IL-10 producing cells within CD24 high CD38 high B cell and CD24 high CD27 + B cells have been broadly linked to immune regulation and control of chronic inflammatory diseases, autoimmunity and graft vs. host disease (11, 12, 17, 27) we decided to assess IL-10 production in these B cell subsets. Our data revealed no differences among the individuals independently of their clinical status, suggesting that B cells from patients with cardiac involvement have a regulatory phenotype mainly due to an expansion in CD24 high CD38 high immature transitional compartment.
Chronic Chagas cardiomyopathy and dilated cardiomyopathy (DCM) have a similar structural disarrangement that leads to ventricular dilatation, but the former is characterized by severe myocarditis and a dense fibrosis that surround each myocardial fiber or group of myocardial fibers (52) . Conversely to our observation, YujieGuo et al (2015) (53) showed that the frequency of CD19 + IL-10 + B cells in peripheral blood from DCM patients was higher than those from healthy individuals under the same stimulation conditions followed in our work. However, when stimulated with CD40L and CpG, the percentage of CD19 + IL-10 + B cells diminished in DCM patients compared to a healthy control group (54) . In addition, the frequency of CD24 high CD38 high transitional B cells and CD24 high CD27 + B cells in DCM patients were comparable with that of healthy individuals, while IL-10 production of CD24 hi CD27 + B cells from DCM patients was decreased.
Although the experimental conditions differ between our study and that by Jiao et al 2018 (54) and this could account for the discrepancies seen in the populations mentioned above, we cannot rule out that these alterations may be responsible of the histopathological findings ascribed to each disease.
Human CD24 high CD38 high immature transitional B cells from healthy individuals seem to inhibit T cell polarization towards Th1 and Th17 profiles while prompting the conversion of CD4 + CD25 -T cells into Treg cells, mainly through IL-10 release (11). However, their function shifts in immune disorders, like in rheumatoid arthritis where transitional B cells fail to convert CD4 + CD25 -T cells into functionally suppressive Treg cells or to restrain Th17 development, albeit maintaining the capacity to inhibit Th1 cell differentiation (55).
This differential activity may be related with the presence of two subsets of CD19 + CD24 hi CD38 hi B cells, the functionally ''conventional'' immature B cells programmed to become mature B cells and the B cells that are functionally regulatory (11) . Notably, the capacity of impairing conversion of T cells towards a Treg cell profile is not an exclusive feature of CD19 + CD24 hi CD38 hi B cells. In DCM, CD24 hi CD27 + B cells have a decreased ability to suppress the TNF-α production by CD4 + CD25 -T cells and to maintain Treg cells differentiation, leading to worsen the cardiac condition (54) .
In summary, our work shows that immature transitional CD24 high CD38 high B cells are greatly expanded in patients with the cardiac form of chronic Chagas disease, and that these cells do not lose their capacity to secrete IL-10 compared to non-infected donors.
This expansion could be the result of defective B cell development during acute T. cruzi infection or may be the consequence of the pro-inflammatory state. Remarkably the distribution of naïve, transitional and memory B cells inside the B10 cells follow the same pattern in chronic patients without cardiac involvement and non-infected individuals.
Finally, our data are insufficient to define whether these immature transitional CD24 high CD38 high B cells have deficiencies in their regulatory function and correlate with the clinical outcome of patients with chronic Chagas disease. We expect that our ongoing in vitro studies aiming at the elucidation of the Breg cells' impact on CD4 + and CD8 + T cells may help to address this matter.
